PLRS,
This looks good,
Pluristem Appoints Yaky Yanay Chief Financial Officer
Wednesday November 1, 7:30 am ET
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS - News), a cell therapy company dedicated to the commercialization of stem cell products, today announced that the Board of Directors has appointed Yaky Yanay as Chief Financial Officer and Company Secretary, replacing Yossi Keret in this position.
ADVERTISEMENT
Prior to joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision System Ltd (EVSNF.OB) a company engaged in automatic optical inspection. He has had extensive experience in financing and management of technology companies, and played a major role in planning and executing a turn around plan of Elbit Vision System, including the completion of three acquisitions and raising more than $20 million, resulting in a tripling of the company's revenues and its attaining profitability.
Mr. Yanay began his financial career at Ernst & Young Israel in 1999, where he served as a manager of audit groups of the technology sector. He joined Ernst & Young's financial team after serving in the Israeli Ministry of Foreign Affairs since 1993.
Mr. Yanay holds a bachelor's degree with honor in business administration and accounting from the college of management studies in Rishon Le Zion, Israel and is a Certified Public Accountant in Israel.
Commenting on the nomination, Mr. Zami Aberman, Pluristem CEO, stated," We are very pleased that Yaky has decided to join our team. I believe that he is the right man at the right time to help enable Pluristem to accomplish its plans of becoming a leading provider of cell therapy products that do not require a match, and target the critical global shortfall of matched tissue for bone marrow transplantation - an unmet need of more than 100,000 patients annually. I would like to thank Yossi Keret for his devoted service and contributions during the past three years and wish him successes in his new challenges |
